The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Drug Delivery to the lungs: Challenges and Opportunities
Abstract
Pulmonary drug delivery is relatively complex because the respiratory tract has evolved defense mechanisms to keep inhaled drug particles out of the lungs and to remove or inactivate them once deposited. In addition to these mechanical, chemical and immunological barriers, pulmonary drug delivery is adversely affected by the behavioral barriers of poor adherence and poor inhaler technique. Strategies to mitigate the effects of these barriers include use of inhaler devices and formulations that deliver drug to the lungs efficiently, appropriate inhaler technique and improved education of patients. Owing to the advantages offered by the pulmonary route, the challenges that the route poses are worth addressing, and if successfully addressed, the pulmonary route offers huge opportunities, often fulfilling unmet clinical needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
What the pulmonary specialist should know about the new inhalation therapies
Laube, B. L., Janssens, H. M., de Jongh, F. H. C., Devadason, S. G., Dhand, R., Diot, P., Everard, M. L., Horvath, I., Navalesi, P., Voshaar, T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00166410 · Cited by 806
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
Dolovich, M. B., Ahrens, R. C., Hess, D. R., Anderson, P., Dhand, R., Rau, J. L., Smaldone, G. C., & Guyatt, G. (2005) · Chest · doi:10.1378/chest.127.1.335 · Cited by 794
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 563
Systematic Review of Errors in Inhaler Use
Sanchis, J., Gich, I., & Pedersen, S. (2016) · CHEST · doi:10.1016/j.chest.2016.03.041 · Cited by 538
Aerosol drug delivery: developments in device design and clinical use
Dolovich, M. B., & Dhand, R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60926-9 · Cited by 505
Medication adherence issues in patients treated for COPD
Restrepo, R. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s3036 · Cited by 407
Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
Price, D., Bosnic-Anticevich, S., Briggs, A., Chrystyn, H., Rand, C., Scheuch, G., & Bousquet, J. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.017 · Cited by 358
Barrier function of airway tract epithelium
Ganesan, S., Comstock, A. T., & Sajjan, U. S. (2013) · Tissue Barriers · doi:10.4161/tisb.24997 · Cited by 345
The History of Therapeutic Aerosols: A Chronological Review
Stein, S. W., & Thiel, C. G. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2016.1297 · Cited by 309
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
Geller, D. E., Weers, J., & Heuerding, S. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0855 · Cited by 308
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., & Cooper, P. J. (2009) · Chest · doi:10.1378/chest.08-1421 · Cited by 281
AL-Jahdali, H., Ahmed, A., AL-Harbi, A., Khan, M., Baharoon, S., Bin Salih, S., Halwani, R., & Al-Muhsen, S. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-8 · Cited by 278
Inhaler reminders improve adherence with controller treatment in primary care patients with asthma
Foster, J. M., Usherwood, T., Smith, L., Sawyer, S. M., Xuan, W., Rand, C. S., & Reddel, H. K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.041 · Cited by 241
The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals
Patton, J. S., Brain, J. D., Davies, L. A., Fiegel, J., Gumbleton, M., Kim, K.-J., Sakagami, M., Vanbever, R., & Ehrhardt, C. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0836 · Cited by 238
Accurate Assessment of Adherence
Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D. (2011) · Chest · doi:10.1378/chest.09-3074 · Cited by 210
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
Lee, W.-H., Loo, C.-Y., Traini, D., & Young, P. M. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.08.009 · Cited by 189
Advances in Metered Dose Inhaler Technology: Formulation Development
Myrdal, P. B., Sheth, P., & Stein, S. W. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-013-0063-x · Cited by 184
The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination
Laube, B. L. (2005) · Respiratory Care · doi:10.4187/respcare.05501161 · Cited by 176
Dry Powder Inhalers: Which Factors Determine the Frequency of Handling Errors?
Wieshammer, S., & Dreyhaupt, J. (2008) · Respiration · doi:10.1159/000109374 · Cited by 169
Scientific rationale for using a single inhaler for asthma control
Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00080306 · Cited by 159
β2‐adrenoceptor agonists: current and future direction
Cazzola, M., Calzetta, L., & Matera, M. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01216.x · Cited by 158
Liposomal Formulations for Inhalation
Cipolla, D. C., Gonda, I., & Chan, H. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.71 · Cited by 153
Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension
Voswinckel, R., Enke, B., Reichenberger, F., Kohstall, M. G., Kreckel, A., Krick, S., Gall, H. J., Gessler, T., Schmehl, T., Ghofrani, H. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(06)01962-0 · Cited by 153
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
Thomas, M. D., Price, D. B., Chrystyn, H., Lloyd, A., Williams, A., & von Ziegenweidt, J. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-1 · Cited by 147
Determinants of Patient Adherence to an Aerosol Regimen
Rau, J. L. (2005) · Respiratory Care · doi:10.4187/respcare.05501346 · Cited by 135
Dumont, J. A., Bitonti, A. J., Clark, D., Evans, S., Pickford, M., & Newman, S. P. (2005) · Journal of Aerosol Medicine · doi:10.1089/jam.2005.18.294 · Cited by 133
Self-citationPulmonary Formulations: What Remains to be Done?
Weers, J. G., Bell, J., Chan, H., Cipolla, D. C., Dunbar, C., Hickey, A. J., & Smith, I. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0838 · Cited by 109
Lewis, A. P., Torvinen, S., Dekhuijzen, P. N. R., Chrystyn, H., Watson, A., Blackney, M., & Plich, A. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1482-7 · Cited by 107
Inhaled insulin--does it become reality?
Siekmeier, R., & Scheuch, G. (2008) · PubMed · Cited by 106
Malmberg, L. P. (2010) · International Journal of COPD · doi:10.2147/copd.s11474 · Cited by 103
Vincken, W., Dekhuijzen, R. P. N., & Barnes, P. J. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00062 · Cited by 97
Inhaled Insulin: A Breath of Fresh Air? A Review of Inhaled Insulin
Cavaiola, T. S., & Edelman, S. V. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.025 · Cited by 96
The Digital Asthma Patient: The History and Future of Inhaler Based Health Monitoring Devices
Kikidis, D., Votis, K., Tzovaras, D. K., & Usmani, O. S. (2016) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1267 · Cited by 92
The Adaptive Aerosol Delivery (AAD) Technology: Past, Present, and Future
Denyer, J., & Dyche, T. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0791 · Cited by 82
Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanism
Pfützner, A., & Forst, T. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1097 · Cited by 79
Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?
Klinger-Strobel, M., Lautenschläger, C., Fischer, D., Mainz, J. G., Bruns, T., Tuchscherr, L. P. N., Pletz, M. W., & Makarewicz, O. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1007949 · Cited by 77
Inhalation, Deposition, and Fate of Insulin and Other Therapeutic Proteins
Brain, J. D. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0228 · Cited by 76
Newman, S. P. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.873402 · Cited by 73
Self-citationDuret, Wauthoz, N., Sebti, Vanderbist, & Amighi (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34091 · Cited by 69
Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis
Hickey, A. J., Misra, A., & Fourie, P. B. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23705 · Cited by 68
Inhaled Drug Delivery in the Hands of the Patient
Lavorini, F. (2014) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2014.1132 · Cited by 60
AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
Kim, E., & Plosker, G. L. (2015) · Drugs · doi:10.1007/s40265-015-0472-0 · Cited by 50
The Design and Performance of the Exubera ® Pulmonary Insulin Delivery System
Harper, N. J., Gray, S. G., Groot, J. D., Parker, J. M., Sadrzadeh, N., Schuler, C. A., Schumacher, J. D., Seshadri, S., Smith, A. E., Steeno, G. S., et al. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0222 · Cited by 45
Arora, S., Haghi, M., Young, P. M., Kappl, M., Traini, D., & Jain, S. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1114603 · Cited by 41
Emerging Technologies for Electronic Monitoring of Adherence, Inhaler Competence, and True Adherence
Pritchard, J. N., & Nicholls, C. (2014) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2014.1163 · Cited by 33
Ari, A., & Fink, J. B. (2015) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1266 · Cited by 21
New and Emerging Treatments for Cystic Fibrosis
Barry, P. J., & Jones, A. M. (2015) · Drugs · doi:10.1007/s40265-015-0424-8 · Cited by 16
Inhaler choice and inhalation technique: key factors for asthma control
Lavorini, F., Levy, M. L., Dekhuijzen, P. R., & Cromptond, G. K. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00069 · Cited by 14
Jones, P. (2015) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815576471 · Cited by 13
Aerosol drug delivery in lung transplant recipients
Corcoran, T. E. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425250802685332 · Cited by 12
Cited by
Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery
Elliott, R. O., & He, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010122 · Cited by 260
Metadata
- Authors
- Newman, S. P.
- Venue
- Therapeutic Delivery
- Publisher
- Informa UK Limited
- Published
- 2017-07
- Volume
- 8
- Issue
- 8
- Pages
- 647-661
- ISSN
- 2041-5990 (ISSN-L)
- 2041-6008
- OpenAlex
- W2738852352
- Cited by
- 328
- References
- 52
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.